If you want to understand how we structure this kind of monitoring, our guide to physician-supervised GLP-1 weight loss in DFW walks through what real supervision looks like, and you can read more about the specific medications on our semaglutide service page
you are getting a dedicated team
As an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, retatrutide is currently undergoing Phase 3 clinical trials for obesity and type 2 diabetes
Ongoing education, monitoring, and communication with your healthcare team are essential for managing side effects and achieving your health goals
FDA-approved branded GLP-1 medications Wegovy, Ozempic, Zepbound, Mounjaro are the same molecules dispensed as finished drug products that completed Novo Nordisk's and Eli Lilly's FDA review and ran the SUSTAIN, STEP, and SURMOUNT trials